Societe Generale and AllianceBernstein announce the official launch of Bernstein, a new leader in cash equities & research

Built on a history of industry-leading research, Bernstein provides institutional investors, corporates and financial institutions with premier investment insights into North American, European and Asia Pacific equity markets, in addition to unparalleled liquidity access and leading global trading technology. With Bernstein, Societe Generale will now offer its clients a comprehensive suite of global services across the equities value-chain, from world-class equity and macro research to leading agency execution, equity derivatives, prime brokerage, and equity capital markets offerings.

With over 750 employees serving clients globally, the joint venture is organised under two separate legal vehicles with a Head Office in New York covering North America and a Head Office in London covering Europe and Asia, complemented by major hubs in Paris and Hong Kong, and multiple regional offices. The ultimate objective of Societe Generale and AllianceBernstein is for Societe Generale to eventually own 100% of both entities after five years^*. Robert van Brugge, previously CEO of Bernstein Research Services, has been appointed CEO of Bernstein, with Stephane Loiseau, previously Head of Societe Generale’s cash equities business, appointed Deputy CEO of Bernstein.

Slawomir Krupa, Chief Executive Officer of Societe Generale, comments: “With Bernstein, a new leader is emerging in cash equities. This joint venture illustrates Societe Generale’s capability to develop innovative pathways to further expand our client offering as we increase our value proposition for the benefit of our investor and issuer clients, leverage synergies within our Group, and grow our revenues sustainably.”

Seth Bernstein, Chief Executive Officer of AllianceBernstein, said: “Bernstein’s mission has a foundation rooted in servicing clients with best-in-class research and insights. Through this joint venture, Bernstein can continue to build out a cash equities and research business that seeks to set the standard for delivering global investment expertise and an even stronger set of products and services for global clients.”

The closing of the transaction has been approved by the relevant regulatory and antitrust authorities. The launch of Bernstein is fully aligned with Societe Generale’s strategic priorities to increase stable, fee-based, client revenues. The impact of the joint venture on the Group's CET1 capital ratio is below 10 basis points.

Biographies

Robert van Brugge has been appointed Chief Executive Officer of Bernstein on 1 April 2024. He has served as the CEO of AB Bernstein Research Services since 2011. Prior to becoming CEO, Robert van Brugge oversaw all fundamental research in his role as the Global Director of Research. He joined Bernstein Research Services in 2002 from McKinsey & Company where he was an associate principal. Before joining McKinsey, Robert van Brugge served as a commercial lender with First Colonial Bankshares Corp. He earned a BA (with honors) in political science and economics from Roosevelt University and an MBA from the Wharton School of the University of Pennsylvania, where he was recognized as a Palmer Scholar.

Stephane Loiseau has been appointed Deputy CEO of Bernstein on 1 April 2024. He was previously Head of Societe Generale’s cash equities business since 2021. Prior to that he held various positions supervising Cash Equities, Prime sales and Listed derivatives trading, based out of Hong Kong since 2012. He also served in London since 2008 as deputy global head of execution services, and head of cash equity execution. Stephane Loiseau joined Societe Generale in 1996 as an international equities trader in New York, before becoming co-head of global program trading and electronic services in 2006. Stephane Loiseau is a graduate of EM Lyon Business School in France.

* The ability of Societe Generale to acquire additional ownership will depend on a number of factors, including obtaining any required regulatory approvals.

Press contacts:
Jean-Baptiste Froville_+33 1 58 98 68 00_jean-baptiste.froville@socgen.com
Benjamin Fayol_+33 1 42 13 08 11_benjamin.fayol@socgen.com
Clare Milton_+44 20 7597 3284_clare.milton@sgcib.com

Download the press release
PDF 139.09 KB